A point-of-care microfluidic biosensing system for rapid and ultrasensitive nucleic acid detection from clinical samples

A point-of-care microfluidic device takes unprocessed clinical samples, actively lyses viral RNAs, and performs the target amplification-free nucleic acid detection with a limit of detection down to 10 aM with 25 min sample-to-result time.